313 related articles for article (PubMed ID: 22469639)
1. Cardiovascular disease and nonalcoholic fatty liver disease: does histologic severity matter?
Domanski JP; Park SJ; Harrison SA
J Clin Gastroenterol; 2012; 46(5):427-30. PubMed ID: 22469639
[TBL] [Abstract][Full Text] [Related]
2. Nonalcoholic fatty liver disease in severely obese subjects.
Gholam PM; Flancbaum L; Machan JT; Charney DA; Kotler DP
Am J Gastroenterol; 2007 Feb; 102(2):399-408. PubMed ID: 17311652
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of liver transplantation in patients with cirrhosis due to nonalcoholic steatohepatitis versus patients with cirrhosis due to alcoholic liver disease.
Bhagat V; Mindikoglu AL; Nudo CG; Schiff ER; Tzakis A; Regev A
Liver Transpl; 2009 Dec; 15(12):1814-20. PubMed ID: 19938128
[TBL] [Abstract][Full Text] [Related]
4. Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients.
Ong JP; Elariny H; Collantes R; Younoszai A; Chandhoke V; Reines HD; Goodman Z; Younossi ZM
Obes Surg; 2005 Mar; 15(3):310-5. PubMed ID: 15826462
[TBL] [Abstract][Full Text] [Related]
5. Predictors of nonalcoholic steatohepatitis (NASH) in obese patients undergoing gastric bypass.
Boza C; Riquelme A; Ibañez L; Duarte I; Norero E; Viviani P; Soza A; Fernandez JI; Raddatz A; Guzman S; Arrese M
Obes Surg; 2005 Sep; 15(8):1148-53. PubMed ID: 16197788
[TBL] [Abstract][Full Text] [Related]
6. Low clinical relevance of the nonalcoholic fatty liver disease activity score (NAS) in predicting fibrosis progression.
Ekstedt M; Franzén LE; Mathiesen UL; Kechagias S
Scand J Gastroenterol; 2012 Jan; 47(1):108-15. PubMed ID: 22126450
[TBL] [Abstract][Full Text] [Related]
7. Patients transplanted for nonalcoholic steatohepatitis are at increased risk for postoperative cardiovascular events.
Vanwagner LB; Bhave M; Te HS; Feinglass J; Alvarez L; Rinella ME
Hepatology; 2012 Nov; 56(5):1741-50. PubMed ID: 22611040
[TBL] [Abstract][Full Text] [Related]
8. The importance of routine liver biopsy in diagnosing nonalcoholic steatohepatitis in bariatric patients.
Shalhub S; Parsee A; Gallagher SF; Haines KL; Willkomm C; Brantley SG; Pinkas H; Saff-Koche L; Murr MM
Obes Surg; 2004 Jan; 14(1):54-9. PubMed ID: 14980034
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus.
Prashanth M; Ganesh HK; Vima MV; John M; Bandgar T; Joshi SR; Shah SR; Rathi PM; Joshi AS; Thakkar H; Menon PS; Shah NS
J Assoc Physicians India; 2009 Mar; 57():205-10. PubMed ID: 19588648
[TBL] [Abstract][Full Text] [Related]
10. Steatohepatitic hepatocellular carcinoma (SH-HCC): a distinctive histological variant of HCC in hepatitis C virus-related cirrhosis with associated NAFLD/NASH.
Salomao M; Yu WM; Brown RS; Emond JC; Lefkowitch JH
Am J Surg Pathol; 2010 Nov; 34(11):1630-6. PubMed ID: 20975341
[TBL] [Abstract][Full Text] [Related]
11. Nonalcoholic fatty liver disease after liver transplantation for cryptogenic cirrhosis or nonalcoholic fatty liver disease.
Yalamanchili K; Saadeh S; Klintmalm GB; Jennings LW; Davis GL
Liver Transpl; 2010 Apr; 16(4):431-9. PubMed ID: 20373454
[TBL] [Abstract][Full Text] [Related]
12. Thrombotic risk factors and liver histologic lesions in non-alcoholic fatty liver disease.
Papatheodoridis GV; Chrysanthos N; Cholongitas E; Pavlou E; Apergis G; Tiniakos DG; Andrioti E; Theodossiades G; Archimandritis AJ
J Hepatol; 2009 Nov; 51(5):931-8. PubMed ID: 19726097
[TBL] [Abstract][Full Text] [Related]
13. Portal fibrosis and hepatic steatosis in morbidly obese subjects: A spectrum of nonalcoholic fatty liver disease.
Abrams GA; Kunde SS; Lazenby AJ; Clements RH
Hepatology; 2004 Aug; 40(2):475-83. PubMed ID: 15368453
[TBL] [Abstract][Full Text] [Related]
14. [Epidemiology and natural history of nonalcoholic fatty liver disease].
Pais R; Ratziu V
Rev Prat; 2012 Dec; 62(10):1416-8, 1420-1. PubMed ID: 23424924
[TBL] [Abstract][Full Text] [Related]
15. The natural history of nonalcoholic fatty liver disease: a clinical histopathological study.
Harrison SA; Torgerson S; Hayashi PH
Am J Gastroenterol; 2003 Sep; 98(9):2042-7. PubMed ID: 14499785
[TBL] [Abstract][Full Text] [Related]
16. Noninvasive assessment of nonalcoholic fatty liver disease in obese or overweight patients.
Francque SM; Verrijken A; Mertens I; Hubens G; Van Marck E; Pelckmans P; Michielsen P; Van Gaal L
Clin Gastroenterol Hepatol; 2012 Oct; 10(10):1162-8; quiz e87. PubMed ID: 22796457
[TBL] [Abstract][Full Text] [Related]
17. Hepatic histology in obese patients undergoing bariatric surgery.
Machado M; Marques-Vidal P; Cortez-Pinto H
J Hepatol; 2006 Oct; 45(4):600-6. PubMed ID: 16899321
[TBL] [Abstract][Full Text] [Related]
18. Non-alcoholic steatohepatitis in children.
Nanda K
Pediatr Transplant; 2004 Dec; 8(6):613-8. PubMed ID: 15598336
[TBL] [Abstract][Full Text] [Related]
19. Natural history of nonalcoholic steatohepatitis.
Liou I; Kowdley KV
J Clin Gastroenterol; 2006 Mar; 40 Suppl 1():S11-6. PubMed ID: 16540761
[TBL] [Abstract][Full Text] [Related]
20. Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years.
Wong VW; Wong GL; Choi PC; Chan AW; Li MK; Chan HY; Chim AM; Yu J; Sung JJ; Chan HL
Gut; 2010 Jul; 59(7):969-74. PubMed ID: 20581244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]